EUVIMEDEUVIMED entdecken
Crossref

Investigation of cytotoxic, molecular and in silico effects of chlorambucil and tamoxifen on 2D/3D MDA-MB-231 and HeLa cancer cell models

Durmuş Burak Demirkaya, Habibe Sema Arslan, Serap Yalcin Azarkan

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-025-11286-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Durmuş Burak Demirkaya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Institute of Science, Kirsehir Ahi Evran University, Kirsehir, Turkey. Hauptthemen laut MEDLINE: Tamoxifen, Chlorambucil, Breast Neoplasms. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Kırşehir Ahi Evran University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to investigate the cytotoxic, morphological, and molecular effects of Tamoxifen (TMX) and Chlorambucil (CHL) on breast cancer (MDA-MB-231) and cervical cancer (HeLa) cell lines. The impact of these agents on metastatic behavior, apoptotic mechanisms, and gene expression profiles was examined in both two-dimensional (2D) and three-dimensional (3D) cell culture models. METHODS: Cells were treated with varying concentrations of TMX and CHL. Cytotoxicity was assessed using the XTT assay, and morphological changes were monitored by microscopy. Migration and invasion assays assessed metastatic potential. VEGFA expression was quantified by qRT-PCR. In 3D cultures, treatment responses were evaluated based on size reduction and structural changes in hydrogel-based spheroids. Docking analysis was conducted to determine binding affinities of TMX and CHL. RESULTS: TMX and CHL exhibited dose-dependent effects on breast and cervical cancer cells. Combination treatment led to significantly greater reductions in cell viability compared to controls (p < 0.05). Moreover, VEGFA expression was markedly reduced in both 2D and 3D models (p < 0.05). These findings support the potential therapeutic value of TMX and CHL. Docking analysis revealed highly negative binding energies, consistent with in vitro results, indicating synergistic interaction at molecular and cellular levels. CONCLUSION: TMX and CHL combination therapy demonstrated potent anti-cancer activity in breast and cervical cancer models, reducing cell viability, metastatic capacity, and VEGFA expression. These results suggest that TMX and CHL, when used together, may represent a promising strategy for developing synergistic and targeted cancer therapies. Further in vivo and clinical validation is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenChlorambucilBreast NeoplasmsHumansHeLa CellsFemaleUterine Cervical NeoplasmsCell SurvivalCell Line, TumorMolecular Docking SimulationApoptosisCell MovementVascular Endothelial Growth Factor AGene Expression Regulation, NeoplasticComputer SimulationCell Proliferation

Stichwörter der Autor:innen

2D and 3D modelsChlorambucilCytotoxicityExpressionTamoxifen

Substanzen

TamoxifenChlorambucilVascular Endothelial Growth Factor AVEGFA protein, human

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Institute of Science, Kirsehir Ahi Evran University, Kirsehir, Turkey.
  • Department of Medical Genetics, Faculty of Medicine, Kirsehir Ahi Evran University, Kirsehir, Turkey.
  • Department of Medical Pharmacology, Faculty of Medicine, Kirsehir Ahi Evran University, Kirsehir, Turkey. syalcin@ahievran.edu.tr.

Förderung

  • Kırşehir Ahi Evran University Scientific Research Projects Coordination Unit

Zitieren

APA

Demirkaya, D. B., Arslan, H. S., & Azarkan, S. Y. (2026). Investigation of cytotoxic, molecular and in silico effects of chlorambucil and tamoxifen on 2D/3D MDA-MB-231 and HeLa cancer cell models. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11286-5

Vancouver

Demirkaya DB, Arslan HS, Azarkan SY. Investigation of cytotoxic, molecular and in silico effects of chlorambucil and tamoxifen on 2D/3D MDA-MB-231 and HeLa cancer cell models. Molecular Biology Reports. 2026. doi:10.1007/s11033-025-11286-5

BibTeX
@article{Demirkaya2026,
  author = {Demirkaya, Durmuş Burak and Arslan, Habibe Sema and Azarkan, Serap Yalcin},
  title = {Investigation of cytotoxic, molecular and in silico effects of chlorambucil and tamoxifen on 2D/3D MDA-MB-231 and HeLa cancer cell models},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-025-11286-5}
}
Kostenlos starten →